Recent Comments

Comment RSS

Chagas Disease News and Research RSS Feed - Chagas Disease News and Research

Chagas (pronounced SHA-gus) disease is named after the Brazilian physician Carlos Chagas, who discovered it in 1909. It is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors that are found only in the Americas (mainly, in rural areas of Latin America where poverty is widespread). Chagas disease (T. cruzi infection) is also referred to as American trypanosomiasis.

People can become infected in various ways. In Chagas-endemic areas, the main way is through vectorborne transmission. The insect vectors are called triatomine bugs. These blood-sucking bugs get infected by biting an infected animal or person. Once infected, the bugs pass T. cruzi parasites in their feces. The bugs are found in houses made from materials such as mud, adobe, straw, and palm thatch. During the day, the bugs hide in crevices in the walls and roofs. During the night, when the inhabitants are sleeping, the bugs emerge. Because they tend to feed on people’s faces, triatomine bugs are also known as “kissing bugs.” After they bite and ingest blood, they defecate on the person. The person can become infected if T. cruzi parasites in the bug feces enter the body through mucous membranes or breaks in the skin. The unsuspecting, sleeping person may accidentally scratch or rub the feces into the bite wound, eyes, or mouth.

Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study

19. November 2009 22:17
Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , ,

Pfizer and DNDi to battle against HAT, VL and Chagas disease

19. November 2009 02:03
Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , , , ,

NIH awards The Tufts CTSI and Tufts University four supplemental grants

27. October 2009 10:10
The Tufts Clinical and Translational Science Institute (CTSI) and Tufts University today announced they are the recipients of four supplemental grant awards from the National Institutes of Health. These new awards, totaling approximately $1.73 million, are supplements to the original Clinical and Translational Science Award (CTSA) grant, UL1 RR025752 that Tufts University received in 2008 from the National Center for Research Resources. [More]

Genzyme named to the 2009 Dow Jones Sustainability World Index

5. October 2009 06:42
Genzyme Corporation announced today that it was included on both the 2009 Dow Jones Sustainability World Index and North American Index. This marks the fifth consecutive year Genzyme has been named to the Dow Jones Sustainability North American Index and the first year the company has been named to the Dow Jones Sustainability World Index. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

Also in Global Health news: U.S. food aid declines; agriculture in Zimbabwe; U.S.-backed ITN network; reducing maternal mortality; DNDI expands; healthcare in Congo

3. October 2009 00:34
Although U.S. food aid funding has increased by 53 percent over the last two years, a Government Accountability Office report on Wednesday said that during the same time period, the "amount of food delivered to address emergencies abroad fell 5 percent," the Washington Independent reports. [More]

Posted in: Disease/Infection News | Healthcare News

Tags: , , ,

Clinton Global Initiative to raise awareness and funding for NTD control and elimination

24. September 2009 07:10
At the Clinton Global Initiative today, the Inter-American Development Bank joined with the Global Network for Neglected Tropical Diseases to announce their commitment to mobilize $30 million from the public and private sectors to raise awareness and funding for NTD control and elimination in the Americas, supported by technical assistance from the Pan American Health Organization, regional office of the World Health Organization for the Americas. [More]

Recent releases: HIV and nutrition; new global health journal; male circumcision; Chagas disease; malaria research methods

14. September 2009 03:13
"Despite calls from national and international organizations to integrate HIV and nutritional programs, data are lacking on how such programs can be effectively implemented in resource-poor settings, on the optimum content and duration of nutritional support, and on ideal target recipients," write the authors of a Clinical Infectious Diseases review that examines the relationship between HIV, nutritional deficiencies and food insecurity. [More]

Posted in: Healthcare News

Tags: , , , ,

Merck partners with non-profit for neglected diseases initiative

23. June 2009 23:02
The pharmaceutical company, Merck, announced Monday it was partnering with the non-profit Drugs for Neglected Diseases initiative (DNDi) in an effort to improve treatments for neglected tropical diseases (NTD), the AP/CNBC reports. [More]

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , ,

Distributed drug discovery for neglected diseases

16. June 2009 02:27
Researchers from Indiana University-Purdue University Indianapolis (IUPUI) have developed Distributed Drug Discovery (D3), a new low-cost strategy to accelerate the discovery of drugs to treat neglected diseases such as tuberculosis, leprosy, leshmaniasis, dengue fever, and Chagas disease. [More]

Posted in: Disease/Infection News

Tags: , , , ,

Swine flu preoccupies world health leaders

14. May 2009 23:36
It is expected that the upcoming World Health Organisation's (WHO) annual assembly will be dominated this year by the emergence and spread of the new influenza virus H1N1 (swine flu). [More]

Many neglected diseases lacking research funding

5. February 2009 03:54
The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine , finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total [More]

Posted in: Disease/Infection News

Tags: , , , , , , , , ,

Scans show immune cells intercepting parasites

10. December 2008 22:27
Researchers may have identified one of the body's earliest responses to a group of parasites that causes illness in developing nations. [More]

Posted in: Medical Science News

Tags: , , , , , ,

New method for testing treatments for Chagas' disease

20. April 2008 23:34
Chagas' disease is a tropical parasitic sickness that currently affects more than 16 million people, with a staggering 100 million at risk, largely in the tropical areas of South and Central America. And yet the main drug used to treat the disease is highly toxic and causes serious side effects. [More]

Posted in: Disease/Infection News

Tags: , , ,

New way to screen for chagas disease in children

28. December 2007 10:47
A new targeted screening strategy could make the diagnosis and treatment of Chagas disease more feasible in low-resource settings, concludes a new study, publishing on December 26, 2007, in the open-access journal PLoS Neglected Tropical Diseases. [More]

Posted in: Disease/Infection News

Tags: ,

Novel approach to discovering drugs for Chagas disease

31. October 2007 10:53
Mexican researchers highlight a novel approach to discovering drugs for Chagas disease in a laboratory study reported in PLoS Neglected Tropical Diseases. [More]

Posted in: Medical Research News

Tags: ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.